It was suggested that ERCC4, as an important component of the ERCC1/ERCC4 heterodimer and a rate-limiting enzyme in the NER pathway, might play a key role in the pathophysiological process of ischemic stroke and that its variations were likely to increase ischemic stroke risk (13). This evidence concerns the gene ERCC4 and ischemic stroke.